Europe’s flying taxi dreams falter as cash runs short

Volocopter The VoloCity made demonstration flights in Paris over the summer One of the innovations at this year’s Paris Olympics was supposed to be an electric flying taxi service. Germany’s Volocopter promised its electric-powered, two-seater aircraft, the VoloCity, would be ferrying passengers around the city. It never happened. Instead the company ran demonstration flights. While…

Read More

Filmmaker Danish Renzu Launches Kashmiri Music Label

Filmmaker Danish Renzu has launched Renzu Music, a label focused on bringing Kashmiri music to mainstream audiences through collaborations with established artists and emerging local talent. The label aims to showcase regional Kashmiri, Balti, and Pahadi-language songs alongside Hindi and English singles. Its roster features artists like Noor Mohammad, Huzaif Nazar, Masrat un Nisa, Abhay…

Read More

Social Media Ban for Children: Australia’s Bill Is Passed

MELBOURNE, Australia — Australia’s House of Representatives on Wednesday passed a bill that would ban children younger than 16 years old from social media, leaving it to the Senate to finalize the world-first law. The major parties backed the bill that would make platforms including TikTok, Facebook, Snapchat, Reddit, X and Instagram liable for fines…

Read More

First Look at Sky and AMC’s “Explosive” Season 3

The blood-soaked violence of Sky and AMC+’s BAFTA-winning Gangs of London continues: a first-look teaser and images for season three were unveiled on Wednesday. The show, starring Ṣọpẹ́ Dìrísù, Joe Cole, Michelle Fairley, Lucian Msamati, and Brian Vernel, was a hit with viewers, gripped by the drug-fuelled chaos in the U.K. capital. Also returning to…

Read More

Hit and Miss for CDK4/6 Inhibitor in Recurrent Brain Cancer

HOUSTON — Progression-free survival for 6 months (PFS6) in recurrent/progressive high-grade meningioma improved more than threefold versus historical outcomes in patients who received the CDK4/6 inhibitor abemaciclib (Verzenio), a preliminary study showed. The first 24 evaluable patients had a PFS6 of 54% as compared with a historical rate of 15%. After enrollment exceeded expectations, analysis…

Read More